CoreFX Ingredients LLC (Booth 5177) has launched its new CoreNhanced website and acquired IP from U.S.-based biotech and life sciences technology developer Disruption Labs, which specializes in advanced nutrient and bioactive delivery systems.

The new CoreNhanced.com platform introduces a dedicated digital space for CoreFX’s advanced nutrient delivery technologies. Visitors can explore how CoreNhanced technology is engineered to transport, deliver, release, and absorb nutrients with precision, translating biotech-inspired and pharmaceutical principles into accessible food, beverage, and supplement applications.

The website reflects CoreFX’s commitment to making clinically relevant nutrition achievable through better formulation and applied science, the company said.

The acquisition of IP from Disruption Labs includes patented and proprietary technologies that strengthen CoreFX’s scientific innovation platform and competitive positioning. This portfolio expands CoreFX’s expertise in emulsification, encapsulation, and micro-structuring, featuring delivery systems designed to improve nutrient stability, absorption, and targeted release.

Integrating this biotech-derived technology into CoreFX’s R&D framework accelerates product development and commercialization across food, beverage, nutraceutical, and specialized health applications, the company said.

“We’re continuing to evolve CoreFX into a science and technology powerhouse that connects clean-label formulation with measurable nutrition,” said Denis Neville, CEO of CoreFX Ingredients. “The launch of CoreNhanced.com and the acquisition of Disruption Labs’ IP position us to bring further innovation and insight directly to our customers, bridging digital engagement with real-world performance.”

CoreFX will highlight these advancements at SupplySide Global Booth 5177, where attendees can experience functional formulation through taste, texture, and technology.

The company’s interactive sampling will feature several new prototypes powered by its CoreNhanced nutrient delivery platform, showcasing how applied life sciences and advanced technologies transform sensitive nutrients into stable, bioavailable, consumer-ready formats.

Metabolic Mango Slushie – Featuring Dry Algal EPA/DHA, recently recognized as a runner-up in the 2025 Ingredient Innovation Awards, plus CoQ10 for heart, metabolic, and cognitive support. This prototype demonstrates how CoreFX’s science-driven lipid delivery systems enhance the stability and absorption of sensitive active compounds in consumer-friendly beverages.

Longevity Greens Beverage – Formulated with Dry DHA and C15:0 Oil, this sample highlights synergistic support for brain, heart, and metabolic health through optimized nutrient transport. The beverage remains shelf-stable while delivering sustained wellness benefits and an enjoyable consumer experience.

Omega Chews – Featuring 60V-T GA Dry Algae Oil 220 in a tropical citrus flavor, these chews show how omega-3s can taste as good as they perform, without the fishy aftertaste.

In addition, a berberine dispersion video demonstration will visualize how CoreFX transforms challenging actives into stable, water-dispersible formats, expanding possibilities for formulation and product innovation.